These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 17245442)

  • 1. Alloimmunisation to donor antigens and immune rejection following foetal neural grafts to the brain in patients with Huntington's disease.
    Krystkowiak P; Gaura V; Labalette M; Rialland A; Remy P; Peschanski M; Bachoud-Lévi AC
    PLoS One; 2007 Jan; 2(1):e166. PubMed ID: 17245442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Donor-Specific Anti-HLA Antibodies in Huntington's Disease Recipients of Human Fetal Striatal Grafts.
    Porfirio B; Paganini M; Mazzanti B; Bagnoli S; Bucciantini S; Ghelli E; Nacmias B; Putignano AL; Rombolà G; Saccardi R; Lombardini L; Di Lorenzo N; Vannelli GB; Gallina P
    Cell Transplant; 2015; 24(5):811-7. PubMed ID: 24380491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of fetal neural transplants in patients with Huntington's disease 6 years after surgery: a long-term follow-up study.
    Bachoud-Lévi AC; Gaura V; Brugières P; Lefaucheur JP; Boissé MF; Maison P; Baudic S; Ribeiro MJ; Bourdet C; Remy P; Cesaro P; Hantraye P; Peschanski M
    Lancet Neurol; 2006 Apr; 5(4):303-9. PubMed ID: 16545746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Striatal allografts in patients with Huntington's disease: impact of diminished astrocytes and vascularization on graft viability.
    Cisbani G; Freeman TB; Soulet D; Saint-Pierre M; Gagnon D; Parent M; Hauser RA; Barker RA; Cicchetti F
    Brain; 2013 Feb; 136(Pt 2):433-43. PubMed ID: 23378216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and anti-HLA antibody profile of nine renal transplant recipients with failed grafts: donor-specific and non-donor-specific antibody development.
    Rebellato LM; Ozawa M; Verbanac KM; Catrou P; Haisch CE; Terasaki PI
    Clin Transpl; 2006; ():241-53. PubMed ID: 18365382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of HLA disparity, immunosuppressive regimen used, and type of kidney allograft on production of anti-HLA class-I antibodies after transplant and occurrence of rejection.
    Abdelnoor AM; Ajib R; Chakhtoura M; Daouk M; Medawar W; Uwaydah M; Sawah SI; Khauli RB
    Immunopharmacol Immunotoxicol; 2009; 31(1):83-7. PubMed ID: 18752168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histological findings on fetal striatal grafts in a Huntington's disease patient early after transplantation.
    Capetian P; Knoth R; Maciaczyk J; Pantazis G; Ditter M; Bokla L; Landwehrmeyer GB; Volk B; Nikkhah G
    Neuroscience; 2009 May; 160(3):661-75. PubMed ID: 19254752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presence of tau pathology within foetal neural allografts in patients with Huntington's and Parkinson's disease.
    Cisbani G; Maxan A; Kordower JH; Planel E; Freeman TB; Cicchetti F
    Brain; 2017 Nov; 140(11):2982-2992. PubMed ID: 29069396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical trials of neural transplantation in Huntington's disease.
    Rosser AE; Bachoud-Lévi AC
    Prog Brain Res; 2012; 200():345-71. PubMed ID: 23195427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term survival of mouse corpus callosum grafts in neonatal rat recipients, and the effect of host sensitization.
    Pollack IF; Lee LH; Zhou HF; Lund RD
    J Neurosci Res; 1992 Jan; 31(1):33-45. PubMed ID: 1613822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transplantation immunology of the brain as a privileged site for neural grafting.
    Mokrý J
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1992; 35(4):307-26. PubMed ID: 1300631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Donor stem cell infusion after non-myeloablative conditioning for tolerance induction to HLA mismatched adult living-donor liver graft.
    Donckier V; Troisi R; Toungouz M; Colle I; Van Vlierberghe H; Jacquy C; Martiat P; Stordeur P; Zhou L; Boon N; Lambermont M; Schandené L; Van Laethem JL; Noens L; Gelin M; de Hemptinne B; Goldman M
    Transpl Immunol; 2004; 13(2):139-46. PubMed ID: 15380544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.
    Strober S
    Blood Cells Mol Dis; 2008; 40(1):48-54. PubMed ID: 17827036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune problems in central nervous system cell therapy.
    Barker RA; Widner H
    NeuroRx; 2004 Oct; 1(4):472-81. PubMed ID: 15717048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human striatal neuroblasts develop and build a striatal-like structure into the brain of Huntington's disease patients after transplantation.
    Gallina P; Paganini M; Lombardini L; Mascalchi M; Porfirio B; Gadda D; Marini M; Pinzani P; Salvianti F; Crescioli C; Bucciantini S; Mechi C; Sarchielli E; Romoli AM; Bertini E; Urbani S; Bartolozzi B; De Cristofaro MT; Piacentini S; Saccardi R; Pupi A; Vannelli GB; Di Lorenzo N
    Exp Neurol; 2010 Mar; 222(1):30-41. PubMed ID: 20026043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What did we learn from neural grafts in Huntington disease?
    Bachoud-Lévi AC
    Rev Neurol (Paris); 2022 May; 178(5):441-449. PubMed ID: 35491247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA mismatches remain risk factors for acute kidney allograft rejection in patients receiving quadruple immunosuppression with anti-interleukin-2 receptor antibodies.
    Wissing KM; Fomegné G; Broeders N; Ghisdal L; Hoang AD; Mikhalski D; Donckier V; Vereerstraeten P; Abramowicz D
    Transplantation; 2008 Feb; 85(3):411-6. PubMed ID: 18322434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does re-exposure to mismatched HLA antigens decrease renal re-transplant allograft survival?
    Farney AC; Matas AJ; Noreen HJ; Reinsmoen N; Segall M; Schmidt WJ; Gillingham K; Najarian JS; Sutherland DE
    Clin Transplant; 1996 Apr; 10(2):147-56. PubMed ID: 8664509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mixed chimerism achieved by a nonlethal conditioning regimen induces donor-specific tolerance to lung allografts.
    Li S; Salgar SK; Kurimoto Y; Yousem S; Pham SM
    J Surg Res; 2008 May; 146(2):289-97. PubMed ID: 18314139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.